FALIPHARMA
ActiveSummary
FALIPHARMA has been active since 1982 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €324,777 and a net result of €47,771. Equity is growing by ~5.7% per year across the filed fiscal years. Its solvency ranks better than 58% of 10519 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability77▲+10
Solvency69▲+3
Growth78▲+26
Track record100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €25,000 at 30 days acceptable
Liquidity ample (current ratio 3.99 against 5.19 in 2024; short-term debt: 18.2% and cash: 33.2% of total assets), but 55.6% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Retail trade (NACE 47)
about 45% more bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
44.4%
Return on assets
6.5%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-07-2026, 7 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
7 d early
2024
19 d late
2023
21 d late
2022
18 d early
2021
25 d early
2020
9 d late
2019
14 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 2 days after the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 24 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
€47,771▲ 46.2%
2024 · €32,672
Working capital
€398,984▲ 6.4%
2024 · €374,929
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€20,958▼ 4.9%€28,471▲ 35.8%€39,154▲ 37.5%€57,643▲ 47.2%€79,739▲ 38.3%
Net result€5,103within the sector's middle half▼ 26.1%€7,664within the sector's middle half▲ 50.2%€18,854within the sector's middle half▲ 146%€32,672within the sector's middle half▲ 73.3%€47,771within the sector's middle half▲ 46.2%
Equity€216,984within the sector's middle half▲ 2.6%€223,848within the sector's middle half▲ 3.2%€242,702within the sector's middle half▲ 8.4%€277,007within the sector's middle half▲ 14.1%€324,777within the sector's middle half▲ 17.2%
Total assets€633,432within the sector's middle half▲ 23.1%€630,970within the sector's middle half▼ 0.4%€661,889within the sector's middle half▲ 4.9%€681,587within the sector's middle half▲ 3.0%€731,975within the sector's middle half▲ 7.4%
Debt€416,448▲ 37.4%€407,122▼ 2.2%€419,186▲ 3.0%€404,580▼ 3.5%€407,198▲ 0.6%
Working capital€317,519within the sector's middle half▼ 8.0%€371,114within the sector's middle half▲ 16.9%€331,874within the sector's middle half▼ 10.6%€374,929within the sector's middle half▲ 13.0%€398,984within the sector's middle half▲ 6.4%
Solvency34.3%within the sector's middle half▼ 6.8pp35.5%within the sector's middle half▲ 1.2pp36.7%within the sector's middle half▲ 1.2pp40.6%within the sector's middle half▲ 4.0pp44.4%within the sector's middle half▲ 3.7pp
Current ratio5.22above the sector's middle half▲ 0.485.99above the sector's middle half▲ 0.774.48above the sector's middle half▼ 1.515.19above the sector's middle half▲ 0.713.99above the sector's middle half▼ 1.20
Return on assets (ROA)0.8%within the sector's middle half▼ 0.5pp1.2%within the sector's middle half▲ 0.4pp2.8%within the sector's middle half▲ 1.6pp4.8%within the sector's middle half▲ 1.9pp6.5%within the sector's middle half▲ 1.7pp
Staff (FTE)3.2within the sector's middle half=3within the sector's middle half▼ 6.3%3within the sector's middle half=3within the sector's middle half=3within the sector's middle half=
above
within
below
the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 38% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €731,975
Fixed assets
€199,480 ▼ 8.1%
Current assets
€532,496 ▲ 14.6%
Equity and liabilities €731,975
Equity
€324,777 ▲ 17.2%
Debt
€407,198 ▲ 0.6%
Debt's share of the balance-sheet total falls from 59.4% to 55.6%. Equity and debt are higher.
Key figures and ratios
EBITDA
€103,174▲
2024 · €80,375
Cash flow
€71,206▲
2024 · €55,404
Quick ratio
2.54▼
2024 · 3.07
Debt to equity
1.25▼
2024 · 1.46
ROE
14.7%▲
2024 · 11.8%
Interest coverage
6.60▲
2024 · 5.07
Debt ≤ 1 year
€133,511▲
2024 · €89,587
Debt > 1 year
€254,112▼
2024 · €305,137
Income taxes
€18,357▲
2024 · €10,842
Staff costs
€161,730▲
2024 · €157,867
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 31,349 companies that looked in July 2024 the way this one looks now, 0.4% went bankrupt within 24 months and 93% are still going.
- Micro
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.4%
went bankrupt
5.9%
stopped otherwise
93%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 0.6% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 31,349 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Remuneration, social security and pensions62 | €136,232 | €142,290 | €149,933 | €157,867 | €161,730 | ▲ 2.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €38,654 | €59,979 | €20,126 | €22,732 | €23,435 | ▲ 3.1% |
| Other operating charges640/8 | €4,898 | €4,978 | €4,427 | €5,053 | €4,795 | ▼ 5.1% |
| Gross operating margin9900 | €200,742 | €235,718 | €213,640 | €243,295 | €269,699 | ▲ 10.9% |
| Operating profit (loss)9901 | €20,958 | €28,471 | €39,154 | €57,643 | €79,739 | ▲ 38.3% |
| Financial income75/76B | €1,492 | €1,139 | €1,439 | €1,719 | €2,014 | ▲ 17.2% |
| Recurring financial income75 | €1,492 | €1,139 | €1,439 | €1,719 | €2,014 | ▲ 17.2% |
| Financial charges65/66B | €14,386 | €16,597 | €15,597 | €15,848 | €15,625 | ▼ 1.4% |
| Recurring financial charges65 | €14,386 | €16,597 | €15,597 | €15,848 | €15,625 | ▼ 1.4% |
| Profit (loss) for the period before taxes9903 | €8,064 | €13,014 | €24,996 | €43,514 | €66,128 | ▲ 52.0% |
| Income taxes67/77 | €2,961 | €5,350 | €6,141 | €10,842 | €18,357 | ▲ 69.3% |
| Profit (loss) for the period9904 | €5,103 | €7,664 | €18,854 | €32,672 | €47,771 | ▲ 46.2% |
| Profit (loss) for the period to be appropriated9905 | €5,103 | €7,664 | €18,854 | €32,672 | €47,771 | ▲ 46.2% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €633,432 | €630,970 | €661,889 | €681,587 | €731,975 | ▲ 7.4% |
| Fixed assets21/28 | €240,746 | €185,481 | €234,599 | €217,072 | €199,480 | ▼ 8.1% |
| Tangible fixed assets22/27 | €234,300 | €179,036 | €228,154 | €210,626 | €193,035 | ▼ 8.4% |
| Land and buildings22 | €206,523 | €170,581 | €156,362 | €142,143 | €128,521 | ▼ 9.6% |
| Plant, machinery and equipment23 | €13,322 | €6,520 | €71,641 | €67,390 | €59,093 | ▼ 12.3% |
| Furniture and vehicles24 | €10,050 | €1,935 | €151 | €1,093 | €5,421 | ▲ 396% |
| Leasing and similar rights25 | €4,405 | - | - | - | - | - |
| Financial fixed assets28 | €6,445 | €6,445 | €6,445 | €6,445 | €6,445 | = |
| Current assets29/58 | €392,686 | €445,489 | €427,290 | €464,515 | €532,496 | ▲ 14.6% |
| Stocks and contracts in progress3 | €151,612 | €159,511 | €173,742 | €189,398 | €193,795 | ▲ 2.3% |
| Stocks30/36 | €151,612 | €159,511 | €173,742 | €189,398 | €193,795 | ▲ 2.3% |
| Amounts receivable within one year40/41 | €64,487 | €77,670 | €139,453 | €68,652 | €89,169 | ▲ 29.9% |
| Trade receivables40 | €61,177 | €72,820 | €139,449 | €68,652 | €85,290 | ▲ 24.2% |
| Other amounts receivable41 | €3,310 | €4,850 | €4 | €0 | €3,879 | - |
| Current investments50/53 | - | - | - | - | €7 | - |
| Cash at bank and in hand54/58 | €176,040 | €204,086 | €106,985 | €202,241 | €243,310 | ▲ 20.3% |
| Deferred charges and accrued income490/1 | €547 | €4,222 | €7,109 | €4,224 | €6,215 | ▲ 47.1% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €633,432 | €630,970 | €661,889 | €681,587 | €731,975 | ▲ 7.4% |
| Equity10/15 | €216,984 | €223,848 | €242,702 | €277,007 | €324,777 | ▲ 17.2% |
| Contributions10/11 | €19,000 | €19,000 | €19,000 | €19,000 | €19,000 | = |
| Reserves13 | €181,740 | €188,603 | €188,603 | €188,603 | €188,603 | = |
| Distributable reserves133 | €181,740 | €188,603 | €188,603 | €188,603 | €188,603 | = |
| Profit (loss) carried forward14 | €16,245 | €16,245 | €35,100 | €69,404 | €117,175 | ▲ 68.8% |
| Amounts payable17/49 | €416,448 | €407,122 | €419,186 | €404,580 | €407,198 | ▲ 0.6% |
| Amounts payable after more than one year17 | €331,314 | €322,760 | €314,036 | €305,137 | €254,112 | ▼ 16.7% |
| Financial debts170/4 | €136,614 | €128,061 | €119,336 | €110,438 | €101,361 | ▼ 8.2% |
| Other amounts payable178/9 | €194,700 | €194,700 | €194,700 | €194,700 | €152,750 | ▼ 21.5% |
| Amounts payable within one year42/48 | €75,168 | €74,376 | €95,415 | €89,587 | €133,511 | ▲ 49.0% |
| Current portion of amounts payable after more than one year42 | €11,955 | €8,553 | €8,724 | €8,899 | €51,026 | ▲ 473% |
| Trade debts44 | €29,475 | €29,359 | €34,341 | €34,480 | €37,419 | ▲ 8.5% |
| Suppliers440/4 | €29,475 | €29,359 | €34,341 | €34,480 | €37,419 | ▲ 8.5% |
| Taxes, remuneration and social security45 | €27,638 | €30,541 | €47,148 | €35,554 | €34,322 | ▼ 3.5% |
| Taxes450/3 | €7,133 | €9,547 | €16,535 | €13,257 | €11,551 | ▼ 12.9% |
| Remuneration and social security454/9 | €20,505 | €20,995 | €30,613 | €22,298 | €22,771 | ▲ 2.1% |
| Other amounts payable47/48 | €6,100 | €5,922 | €5,201 | €10,654 | €10,744 | ▲ 0.8% |
| Accrued charges and deferred income492/3 | €9,966 | €9,986 | €9,735 | €9,856 | €19,575 | ▲ 98.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €5,103 | €7,664 | €18,854 | €32,672 | €47,771 | ▲ 46.2% |
| + Depreciation and write-downs630 | €38,654 | €59,979 | €20,126 | €22,732 | €23,435 | ▲ 3.1% |
| Operating cash flow (approximation) | €43,757 | €67,643 | €38,980 | €55,404 | €71,206 | ▲ 28.5% |
| Investment in fixed assets (approximation) | - | -€4,714 | -€69,244 | -€5,204 | -€5,844 | ▼ 12.3% |
| Change in cash | - | €28,046 | -€97,101 | €95,256 | €41,069 | ▼ 56.9% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
04-08
State Gazette act
Permanent representative: Céline RUTHRegistered-office move4 facts ▸
State Gazette act
Permanent representative: Céline RUTH
Registered-office move4 facts ▸
- General meeting, 05-05-2026
- Registered-office move, Rue J.J. Merlot(FAL) 3A - 5060 Sambreville
- Permanent representative, Céline RUTH (permanent representative)
- Director in office, JAROLINE PHARMA SRL (director)
24-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Highest result since 2018net €47,771 ▲46.2%
Operating result €79,739, net result €47,771, both a record.
19-08
NBB filing
Annual accounts filed
fiscal year 2024 · full schema · 19 days late
2024
21-08
NBB filing
Annual accounts filed
fiscal year 2023 · full schema · 21 days late
2023
13-07
NBB filing
Annual accounts filed
fiscal year 2022 · full schema
2022
06-07
NBB filing
Annual accounts filed
fiscal year 2021 · full schema
2021
09-08
NBB filing
Annual accounts filed
fiscal year 2020 · full schema · 9 days late
2020
14-08
NBB filing
Annual accounts filed
fiscal year 2019 · full schema · 14 days late
2019
31-12
Financial
Weakest financial yearnet €4,233 ▼87.7%
Net result drops to €4,233, the lowest in the series; recovery starts the following year.
16-09
NBB filing
Annual accounts filed
fiscal year 2018 · full schema · 47 days late
2018
29-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 29 days late
2017
26-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 4 acts read
About the unread acts
Of the 4 Belgian State Gazette acts we know for this company, 1 has been read. The other 3 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 1. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Sambreville · 2 establishment units since 1982
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue J.J. Merlot(FAL) 35060 SambrevilleGround area
638 m²
Building footprint
82 m²
Parcel 92041A0075/00Z003, Wallonia. Linked by address, not a title deed.
2 establishment units
Rue J.J. Merlot(FAL) 23, 5060 Sambreville
since 19822.020.968.868
Rue de Fosses(FAL) 17, 5060 Sambreville
since 19822.020.968.967
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92041A0075/00Z003 | Wallonia | 638 m² | 1 · 82 m² | - |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Structure & network
Owners and holdings
1 ownerChain of control
- Jaroline Pharma
- FALIPHARMA
Highest known parent: Jaroline Pharma. The sources do not say who stands above it.
Owners 1
- Jaroline Pharmaparent100%
Holdings 0
No holding stated in the accounts, acts or LEI register we read.
According to the annual accounts of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.
Connections & network
No current directors or connected companies found in the register.
Recognitions · licences · registrations
Food safety, FASFC
2 sitesSambreville2.020.968.868
Sambreville2.020.968.967
Similar companies · same sector, comparable size
MAUDENS JEROEN
BE 0884.829.347
Sint-Genesius-Rode · Eq €324,786
OSTEOSERV
BE 0870.735.346
Kinrooi · Eq €324,795
STEVENS PHARMA
BE 0442.284.960
Wezembeek-Oppem · Eq €324,659
PHARMACIE MARIE-ANNE LEFEBURE
BE 0827.755.141
Sint-Pieters-Woluwe · Eq €324,897
APOTHEEK DE LOORE ZWEVEZELE
BE 0898.945.619
Wingene · Eq €325,065
Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,486 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded31-08-1982
Fiscal year end31-12
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
E-invoicing
Reachable via Peppol
Peppol ID
0208:0422990373
Also
9925:BE0422990373
Registered
11-12-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.